Skip to main content
SpringerLink
Log in

Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The effects of substance P, neurokinin A, neurokinin B, [Sar9, Met(O2)11]-substance P, [Nle10]neurokinin A (4–10) and senktide {succinyl-[Asp6, McPhe8]-substance P (6–11)} on blood pressure and heart rate were studied in anesthetized dogs. Dose-dependent decreases in blood pressure and increases in heart rate were caused by each peptide except senktide. The latter elicited weak hypotensive or hypertensive responses at high doses. The order or potency was as follows: [Sar9, Met(O2)11]-substance P ≥ substance P > neurokinin ß1 > neurokinin B > [Nle10]-neurokinin A (4–10) » senktide.

CP-96,345, [(2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)-methyl]-1-azabicyclo[2.2.2]octan-3-amine] a selective NK-1 tachykinin receptor blocker, inhibited substance P-induced hypotension in a dose-related manner. R responses to each of the other peptides were inhibited by CP-96,345, 1.0 mg/kg (excluding senktide against which CP-96,345 was not tested). CP-96,344 (1.0 mg/kg i.v.) the 2R-3R enantiomer of CP-96,345 which does not block NK-1 receptors, had no effect on substance P-induced hypotension. We conclude that tachykinin-induced hypotension in dogs is mediated by NK-1 tachykinin receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Burcher E, Atterhög J-H, Pernow B, Rosell S (1977) Cardiovascular effects of substance P: Effects on the heart and regional blood flow in the dog. In: von Euler US, Pernow B (eds) Substance P. Raven Press, New York, pp 261–268

    Google Scholar 

  • Bury RW, Mashford ML (19771) Review. Substance P: Its pharmacology and physiological roles. Aust J Exp Biol Med Sci 55:671–735

    Google Scholar 

  • Bury RW, Mashford ML (1977b) Cardiovascular effects of synthetic substance P in several species. Eur J Pharmacol 45:335–340

    Google Scholar 

  • Constantine JW, Lebel WS, Woody HA (1990) Smooth muscle of rabbit isolated aorta contains the NK-2 tachykinin receptor. Naunyn-Schmiedeberg's Arch Pharmacol 342:722–724

    Google Scholar 

  • D'Orléans-Juste P, Dion S, Mizrahi J, Regoli D (1985) Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol 114:9–21

    Google Scholar 

  • Drapeau G, D'Orleans-Juste P, Dion S, Rhaleb N-E, Rouissi N-E, Regoli D (1987) Selective agonists for substance P and neurokinin receptors. Neuropeptides 10:43–54

    Google Scholar 

  • Henry JL (1987) Discussions of nomenclature for tachykinins and tachykinin receptors. In: Henry JL, Couture R, Cuello AC, Pelletier G, Quirion R, Regoli D (eds) Substance P and Neurokinins. Springer, Berlin Heidelberg New York Tokyo, pp xvii-xviii

    Google Scholar 

  • Losay J, Mroz EA, Tregear GW, Leeman SE, Gamble WJ (1977) Action of substance P on the coronary blood flow in the isolated dog heart. In: von Euler US, Pernow B (eds) Substance P. Raven Press, New York, pp 287–293

    Google Scholar 

  • Mastrangelo D, Mathison R, Huggel HJ, Dion S, D'Orléans-Juste P, Rhaleb NE, Drapeau G, Rovero P, Regoli D (1986) The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Eur J Pharmacol 134:321–326

    Google Scholar 

  • Regoli D, Drapeau G, Dion S, D'Orléans-Juste P (1987) Minireview. Pharmacological receptors for substance P and neurokinins. Life Sci 40:109–117

    Google Scholar 

  • Regoli D, Drapeau G, Dion S, Couture R (1988) New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Trends Pharmacol Sci 9:290–295

    Google Scholar 

  • Rouissi N, Gitter BD, Waters DC, Howbert JJ, Nixon JA, Regoli D (1991) Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. Biochem Biophys Res Commun 176:894–901

    Google Scholar 

  • Snider RM, Constantine JW, Lowe III JA, Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC, Vinick FJ, Spencer RW, Hess H-J (1991) A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 251:435–437

    Google Scholar 

  • Wormser U, Laufer R, Hart Y, Chorev M, Gilon C, Selinger Z (1986) Highly selective agonists for substance P receptor subtypes. EMBO J 5:2805–2808

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Exploratory Medicinal Chemistry, Central Research Division, Pfizer Inc., Eastern Point Road, 06340, Groton, CT, USA

    Jay W. Constantine, Wesley S. Lebel & Heidi A. Woody

Authors
  1. Jay W. Constantine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wesley S. Lebel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Heidi A. Woody
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Send offprint requests to J. W. Constantine at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Constantine, J.W., Lebel, W.S. & Woody, H.A. Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 344, 471–477 (1991). https://doi.org/10.1007/BF00172588

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00172588

Keywords

Search

Navigation